Shanxi Zhendong Pharmaceutical Cash Flow Conversion Efficiency
Shanxi Zhendong Pharmaceutical cash flow conversion efficiency. Based on the latest financial reports, Shanxi Zhendong Pharmaceutical (300158) has a cash flow conversion efficiency ratio of -0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-197.94 Million ≈ $-28.96 Million USD) by net assets (CN¥3.63 Billion ≈ $530.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shanxi Zhendong Pharmaceutical (2007–2024)
Cash flow conversion efficiency of Shanxi Zhendong Pharmaceutical from 2007 to 2024. This chart illustrates how Shanxi Zhendong Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shanxi Zhendong Pharmaceutical stock price for real-time trading data and today's change.
Shanxi Zhendong Pharmaceutical Cash Flow Conversion Ratio Explained
Shanxi Zhendong Pharmaceutical cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shanxi Zhendong Pharmaceutical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanxi Zhendong Pharmaceutical ranked by their cash flow conversion efficiency. Also see 300158 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mrs. Bectors Food Specialities Limited
NSE:BECTORFOOD
|
0.084x |
|
Shanghai Maling Aquarius Co Ltd
SHG:600073
|
0.146x |
|
Tainan Spinning Co Ltd
TW:1440
|
0.019x |
|
AhnLab Inc
KQ:053800
|
0.062x |
|
AGF Management Limited
F:A3J
|
0.041x |
|
Beingmate Baby & Child Food Co Ltd
SHE:002570
|
0.013x |
|
First Watch Restaurant Group Inc
NASDAQ:FWRG
|
0.043x |
|
ITE Tech Inc
TW:3014
|
0.062x |
Annual Cash Flow Conversion Efficiency for Shanxi Zhendong Pharmaceutical (2007–2024)
The table below shows the annual cash flow conversion efficiency of Shanxi Zhendong Pharmaceutical from 2007 to 2024. Review 300158 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.66 Billion ≈ $535.61 Million |
CN¥-149.82 Million ≈ $-21.92 Million |
-0.041x | -10.85% |
| 2023-12-31 | CN¥5.14 Billion ≈ $752.74 Million |
CN¥-189.95 Million ≈ $-27.80 Million |
-0.037x | -323.47% |
| 2022-12-31 | CN¥5.22 Billion ≈ $764.33 Million |
CN¥86.31 Million ≈ $12.63 Million |
0.017x | -53.21% |
| 2021-12-31 | CN¥8.05 Billion ≈ $1.18 Billion |
CN¥284.45 Million ≈ $41.62 Million |
0.035x | -10.36% |
| 2020-12-31 | CN¥5.63 Billion ≈ $824.31 Million |
CN¥221.94 Million ≈ $32.48 Million |
0.039x | +15.04% |
| 2019-12-31 | CN¥5.44 Billion ≈ $796.21 Million |
CN¥186.35 Million ≈ $27.27 Million |
0.034x | +18.89% |
| 2018-12-31 | CN¥5.36 Billion ≈ $784.69 Million |
CN¥154.48 Million ≈ $22.60 Million |
0.029x | +255.11% |
| 2017-12-31 | CN¥5.56 Billion ≈ $813.28 Million |
CN¥45.09 Million ≈ $6.60 Million |
0.008x | +195.63% |
| 2016-12-31 | CN¥5.27 Billion ≈ $771.41 Million |
CN¥-44.72 Million ≈ $-6.54 Million |
-0.008x | -111.34% |
| 2015-12-31 | CN¥2.03 Billion ≈ $297.12 Million |
CN¥151.84 Million ≈ $22.22 Million |
0.075x | +101.19% |
| 2014-12-31 | CN¥1.97 Billion ≈ $288.29 Million |
CN¥73.23 Million ≈ $10.72 Million |
0.037x | +197.00% |
| 2013-12-31 | CN¥1.96 Billion ≈ $286.56 Million |
CN¥-75.04 Million ≈ $-10.98 Million |
-0.038x | -138.43% |
| 2012-12-31 | CN¥1.90 Billion ≈ $277.96 Million |
CN¥189.40 Million ≈ $27.72 Million |
0.100x | +308.83% |
| 2011-12-31 | CN¥1.86 Billion ≈ $271.95 Million |
CN¥-88.73 Million ≈ $-12.98 Million |
-0.048x | -362.53% |
| 2010-12-31 | CN¥1.78 Billion ≈ $260.67 Million |
CN¥32.40 Million ≈ $4.74 Million |
0.018x | -84.54% |
| 2009-12-31 | CN¥359.31 Million ≈ $52.58 Million |
CN¥42.28 Million ≈ $6.19 Million |
0.118x | -5.43% |
| 2008-12-31 | CN¥266.72 Million ≈ $39.03 Million |
CN¥33.18 Million ≈ $4.86 Million |
0.124x | -82.94% |
| 2007-12-31 | CN¥176.42 Million ≈ $25.82 Million |
CN¥128.65 Million ≈ $18.82 Million |
0.729x | -- |
About Shanxi Zhendong Pharmaceutical
Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sales of pharmaceutical drugs in China. It offers drugs for various fields, including tumors, dermatology, digestion, urology, and cardio-cerebral drugs. The company also provides Chinese herbal medicines. Shanxi Zhendong Pharmaceutical Co.,Ltd was founded in 1995 and is b… Read more